Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand
about
Role of neurosteroids in the anticonvulsant activity of midazolamTranslocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effectsGanaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorderMidazolam ameliorates the behavior deficits of a rat posttraumatic stress disorder model through dual 18 kDa translocator protein and central benzodiazepine receptor and neurosteroidogenesisRo5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats.Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain.Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) ReceptorsUp-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorderGABAA receptors as targets for novel anxiolytic drugs.Targeting neurosteroidogenesis as therapy for PTSD.The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus.Effect of ZBD-2 on chronic pain, depressive-like behaviors, and recovery of motor function following spinal cord injury in mice.Emerging drugs for panic disorder.Progesterone and its metabolites as therapeutic targets in psychiatric disorders.The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy.Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N-Dialkyl-2-arylindol-3-ylglyoxylamides.TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Sex-dependent mental illnesses and mitochondria.Elevated Neurosteroids in the Lateral Thalamus Relieve Neuropathic Pain in Rats with Spared Nerve Injury.The Novel Dipeptide Translocator Protein Ligand, Referred to As GD-23, Exerts Anxiolytic and Nootropic Activities.Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.Anxiolytic effects of hippocampal neurosteroids in normal and neuropathic rats with spared nerve injury.Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216.Insufficient intake of L-histidine reduces brain histamine and causes anxiety-like behaviors in male mice.Antidepressant-Like and Anxiolytic-Like Effects of ZBD-2, a Novel Ligand for the Translocator Protein (18 kDa).A novel translocator protein 18 kDa ligand, ZBD-2, exerts neuroprotective effects against acute spinal cord injury.Neuroprotective effects of a novel translocator protein (18 kDa) ligand, ZBD-2, against focal cerebral ischemia and NMDA-induced neurotoxicity.
P2860
Q24614956-10EE429A-4B21-47F3-8DE1-D882CBCBF8DFQ28249253-62DE2A94-CF4B-4AF2-A017-7A99CFB55016Q30428666-1C38343A-CB4F-47BC-A981-FBDD9C96B203Q30435243-183DEE71-579A-4391-B0B7-86A3824AD0A6Q34760717-BD701D83-996B-472A-8F04-16DB39E3F0EFQ35368630-7278ADF7-1E37-4DF1-8415-8D2FF2A7A44CQ35600228-07306F1B-2334-4C97-9E96-83D112E82F71Q35631836-58D5F1C6-EC7F-4708-9300-FDCE2120A962Q36637673-C560A307-0266-46B6-B7E5-D09AF0E8E91DQ37433677-8375FDAE-ACBD-4FBB-A56B-2E605934552DQ37438943-0A09A7A4-566C-4C2C-A4BD-ED539110B499Q37683352-55C0423A-EBA4-4B98-873C-BB8628BDE7BDQ37945699-0B18553D-5768-4BDD-87AF-899299227A0FQ38198091-DEE09B57-B4FF-452B-8FD5-FD03B46E72A6Q38221277-1BD37F3A-15FC-4BE1-A126-88125709BCFAQ38688144-C36A68FA-0AF8-4AF3-A32A-0A1660481405Q38805094-CF722161-5014-482A-A4B1-2466660CF227Q38949384-819D146A-95DC-492C-9B78-10FA34A869EEQ39171620-6E1FA4B1-8B02-42C3-8339-A83ED3C717FDQ41465921-10F665E3-26F2-41E0-A2C3-E8D43696D327Q41819548-8B3BED57-B2C0-4AFA-8EDD-E75B7F41081CQ47291761-820EF19D-12C1-479B-A87E-8347E77016AAQ47349454-FBD61E3A-EE81-4ABD-887E-732DB4ABBC27Q47595050-3A8CCDDF-8843-4422-BB0A-F2C30CA42D20Q47842191-A3908831-E765-4D47-B1BA-32D50DCF41AEQ48044683-336D4CF1-1445-48EC-A2E2-09D288D61F89Q51706942-6622FEBA-AECD-4242-8EB1-3F5990EA9452Q52152073-85803D05-AB45-4655-A767-C405B2DA614F
P2860
Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@ast
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@en
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@nl
type
label
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@ast
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@en
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@nl
prefLabel
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@ast
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@en
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@nl
P2093
P2860
P356
P1476
Antianxiety and antidepressant ...... benzodiazepine receptor ligand
@en
P2093
Atsuko Kita
Hitoshi Kohayakawa
Keiko Nakamichi
Kiyoshi Furukawa
Makoto Oka
Satoshi Kurumiya
Tomoko Kinoshita
Yoshiaki Ochi
P2860
P304
P356
10.1038/SJ.BJP.0705681
P407
P577
2004-08-01T00:00:00Z